OptumHealth New Mexico: Treatment and Support Services for Women with Substance Use or Co-Occurring DisordersDeadline: September 15, 2014
OptumHealth is procuring services for veterans in collaboration with the New Mexico Interagency Behavioral Health Purchasing Collaborative. This funding is state general funds and is provided on behalf of the Human Services Department, Behavioral Health Services Division (BHSD). OptumHealth is seeking proposals for treatment services to women who have substance use disorders or have a co-occurring disorder, with preference given to areas of the state that are underserved. OptumHealth/BHSD seeks to fund programs that address the unmet needs of women and their families. The intended population is New Mexico women age 18+ with substance use or co-occurring disorders in need of support services to address unmet needs for themselves and/or their families. An Offeror may submit a proposal to address one or all or any combination of the services defined below:
- Clinical treatment services: those services necessary to address the medical and biopsychosocial issues of addiction and co-occurring disorders;
- Clinical support services: services that assist clients in their recovery; and/or
- Community support services: those services and community resources outside of treatment but within a community that serve as an underpinning or support system for the recovering individual.
Eligibility: Offerors must deliver services using the principles of Trauma Informed Care (TIC), and be familiar with Recovery Oriented System of Care (ROSC) and apply the practice and principles of ROSC. Preference will be given to programs that demonstrate service provision to: 1) pregnant injecting drug users; and 2) pregnant substance users. Preference will also be given to programs that are located in rural and frontier areas of New Mexico that serve underserved populations, i.e. Native Americans, LGBTQ; programs that collaborate with other community providers; and/or specialty programs or services that are specifically designed to treat women with substance use disorders or those with a co-occurring disorder.
Note: An Acknowledgement of Receipt form is due August 28, 2014.